Featured Research

from universities, journals, and other organizations

Antibiotic resistance among hospital-acquired infections is much greater than prior CDC estimates

Date:
August 1, 2013
Source:
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed)
Summary:
Hospital-acquired infections' antibiotic resistance is higher than prior CDC reports, and the FDA's reboot of its antibiotic development rules to combat these infections has fallen short.

The rise of antibiotic resistance among hospital-acquired infections is greater than the Centers for Disease Control and Prevention (CDC) found in its 2008 analysis, according to an ahead-of-print article in the journal, Antimicrobial Agents and Chemotherapy.

The article also finds that the Food and Drug Administration's (FDA) promise to "reboot" antibiotic development rules a year ago to combat the rise in resistance has fallen short.

The commentary, whose authors include Brad Spellberg, MD, a Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) infectious disease specialist, analyzed privately gathered data and concluded antibiotic resistance among hospital-acquired infections is "at crisis levels." The FDA's "reboot" pledge to encourage the development of new antibiotics to battle this resistance "cannot come too soon" but "will not be enough," the authors conclude.

"With antibiotic-resistant microbes infecting more than 2 million Americans every year and killing more than 100,000 annually, we must act to find new weapons in the global battle against deadly Superbugs," said Dr. Spellberg, M.D., who authored "Rising Plague," a book on antibiotic resistance. "Our analysis found the rise in antibiotic resistance among three common forms of hospital-acquired infections is much greater than previously reported by the CDC based on older data, leading us to conclude that more than an FDA 'reboot' is needed. To encourage antibiotic development, the pharmaceutical industry must see that there is a path for a return on its investment in antibiotic development."

The authors found "very positive aspects" in the FDA's most recent guidance for antibacterial therapies for patients with unmet medical needs. But they said the FDA's approach to the development of antibacterials in traditional indications, such as pneumonia and urinary tract infections, "has been mixed."

Their findings on the rise on antibiotic resistance among hospital-acquired infections include:

  • The resistance for acinetobacter (A. baumannii) to carbapenems is more than 50%. The CDC found it to be 11%. Carbapenems are among the last available antibiotics. If they don't work, only one or two other drugs are left to battle these infections. Neither is very effective, and one is highly toxic.
  • The resistance among E. coli to third generation cephalosporins (a class of antibiotics) was 8-11%. The CDC found it to be 5%.
  • The resistance to klebsiella (K. pneumonia) to third generation cephalosporins was 20-27%. The CDC found it to be 15%. Resistance to carbapenems among these isolates is now between 7 and 11%.
  • Carbapenems are already obsolete for a common Intensive Care Unit infection, Acinetobacter baumannii. "This holds true for both intensive care and non-intensive care patients and for urinary and non-urinary infections," the commentary says.

"None of the antibiotics under development today can address all of these antibiotic-resistant infections," said Dr. Spellberg. "A complete overhaul of the approaches to resistance, disease and prevention could change the continuing upward trajectory of antibiotic resistant infections. To do anything less invites a bleak post-antibiotic future, in which infectious diseases once again reign supreme."


Story Source:

The above story is based on materials provided by Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed). Note: Materials may be edited for content and length.


Journal Reference:

  1. D. M. Shlaes, D. Sahm, C. Opiela, B. Spellberg. Commentary: The FDA Reboot of Antibiotic Development. Antimicrobial Agents and Chemotherapy, 2013; DOI: 10.1128/AAC.01277-13

Cite This Page:

Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed). "Antibiotic resistance among hospital-acquired infections is much greater than prior CDC estimates." ScienceDaily. ScienceDaily, 1 August 2013. <www.sciencedaily.com/releases/2013/08/130801113222.htm>.
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed). (2013, August 1). Antibiotic resistance among hospital-acquired infections is much greater than prior CDC estimates. ScienceDaily. Retrieved September 20, 2014 from www.sciencedaily.com/releases/2013/08/130801113222.htm
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed). "Antibiotic resistance among hospital-acquired infections is much greater than prior CDC estimates." ScienceDaily. www.sciencedaily.com/releases/2013/08/130801113222.htm (accessed September 20, 2014).

Share This



More Health & Medicine News

Saturday, September 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Sierra Leone's Nationwide Ebola Curfew Underway

Sierra Leone's Nationwide Ebola Curfew Underway

Newsy (Sep. 20, 2014) Sierra Leone is locked down as aid workers and volunteers look for new cases of Ebola. Video provided by Newsy
Powered by NewsLook.com
Changes Found In Brain After One Dose Of Antidepressants

Changes Found In Brain After One Dose Of Antidepressants

Newsy (Sep. 19, 2014) A study suggest antidepressants can kick in much sooner than previously thought. Video provided by Newsy
Powered by NewsLook.com
Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com
Jury Delivers Verdict in Salmonella Trial

Jury Delivers Verdict in Salmonella Trial

AP (Sep. 19, 2014) A federal jury has convicted three people in connection with an outbreak of salmonella poisoning five years ago that sickened hundreds of people and was linked to a number of deaths. (Sept. 19) Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins